ESR2 and breast cancer: Although 27-HC causes a conformational change in both the ERα and ERβ 2, and ERβ is described to be expressed in both ERα+ and ERα- tumors, however a significant heterogeneity in the association of circulating 27-HC and BC risk by ERβ has not been yet identified 93.